NASDAQ:ALLO | EBITDA | Allogene Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2018-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$43.22M
2025-12-31-$39.35M
2025-03-31-$62.09M
2024-12-31-$57.26M
2024-03-31-$65.95M
2023-12-31-$81.63M

Annual EBITDA

DateEBITDA
2025-12-31-$196.96M
2024-12-31-$259.56M
2023-12-31-$313.54M
2022-12-31-$321.24M
2021-12-31-$169.69M
2020-12-31-$250.84M
2019-12-31-$197.41M
2018-12-31-$191.84M